Rankings
▼
Calendar
RAPT Q4 2024 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
$959M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$54M
Net Income
-$53M
EPS (Diluted)
$-9.12
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$240M
Total Liabilities
$50M
Stockholders' Equity
$190M
Cash & Equivalents
$170M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$54M
-$33M
-64.0%
Net Income
-$53M
-$31M
-72.5%
← FY 2024
All Quarters
Q1 2025 →